MENU
+Compare
CVKD
Stock ticker: NASDAQ
AS OF
Aug 25 closing price
Price
$12.32
Change
-$0.16 (-1.28%)
Capitalization
25.54M

CVKD Cadrenal Therapeutics Inc Forecast, Technical & Fundamental Analysis

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy... Show more

CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CVKD with price predictions
Aug 25, 2025

CVKD in upward trend: 10-day moving average moved above 50-day moving average on August 20, 2025

The 10-day moving average for CVKD crossed bullishly above the 50-day moving average on August 20, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 12, 2025. You may want to consider a long position or call options on CVKD as a result. In of 46 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CVKD just turned positive on August 07, 2025. Looking at past instances where CVKD's MACD turned positive, the stock continued to rise in of 25 cases over the following month. The odds of a continued upward trend are .

CVKD moved above its 50-day moving average on August 14, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CVKD advanced for three days, in of 129 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CVKD moved out of overbought territory on August 20, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 9 similar instances where the indicator moved out of overbought territory. In of the 9 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 30 cases where CVKD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVKD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CVKD broke above its upper Bollinger Band on August 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CVKD entered a downward trend on August 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.865) is normal, around the industry mean (19.083). P/E Ratio (0.000) is within average values for comparable stocks, (54.504). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.646). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (304.949).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CVKD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVKD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CVKD is expected to report earnings to fall 25.67% to -138 cents per share on November 06

Cadrenal Therapeutics Inc CVKD Stock Earnings Reports
Q3'25
Est.
$-1.39
Q2'25
Missed
by $0.61
Q4'24
Missed
by $1.88
Q3'24
Missed
by $2.06
Q2'24
Missed
by $2.13
The last earnings report on August 11 showed earnings per share of -187 cents, missing the estimate of -125 cents. With 13.96K shares outstanding, the current market capitalization sits at 25.54M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
822 A1A North
Phone
+1 904 300-0701
Employees
4
Web
https://www.cadrenal.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OGI1.630.03
+1.87%
Organigram Global Inc
COHN12.25-0.07
-0.57%
Cohen & Company
TMP69.50-0.89
-1.26%
Tompkins Financial Corp
DEO113.64-1.69
-1.47%
Diageo plc
ALKS29.00-0.75
-2.52%
Alkermes plc

CVKD and Stocks

Correlation & Price change

A.I.dvisor tells us that CVKD and GDTC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and GDTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
-1.30%
GDTC - CVKD
29%
Poorly correlated
+6.67%
MNPR - CVKD
27%
Poorly correlated
-5.12%
NEVPF - CVKD
27%
Poorly correlated
N/A
YMAB - CVKD
25%
Poorly correlated
-0.12%
WHWK - CVKD
25%
Poorly correlated
-2.30%
More